These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
173 related articles for article (PubMed ID: 24364139)
1. [A molecular basis of the plague vaccine development]. Dentovskaia SV; Kopylov PKh; Ivanov SA; Ageev SA; Anisimov AP Mol Gen Mikrobiol Virusol; 2013; (3):3-12. PubMed ID: 24364139 [TBL] [Abstract][Full Text] [Related]
2. Live-attenuated Yersinia pestis vaccines. Wang X; Zhang X; Zhou D; Yang R Expert Rev Vaccines; 2013 Jun; 12(6):677-86. PubMed ID: 23750796 [TBL] [Abstract][Full Text] [Related]
3. The natural history and incidence of Yersinia pestis and prospects for vaccination. Williamson ED; Oyston PCF J Med Microbiol; 2012 Jul; 61(Pt 7):911-918. PubMed ID: 22442294 [TBL] [Abstract][Full Text] [Related]
4. Current challenges in the development of vaccines for pneumonic plague. Smiley ST Expert Rev Vaccines; 2008 Mar; 7(2):209-21. PubMed ID: 18324890 [TBL] [Abstract][Full Text] [Related]
16. Cell-mediated immune response and Th/Th cytokine profile of B-T constructs of F1 and V antigen of Yersinia pestis. Gupta G; Khan AA; Rao DN Scand J Immunol; 2010 Mar; 71(3):186-98. PubMed ID: 20415784 [TBL] [Abstract][Full Text] [Related]
17. Newly described cell type may prove valuable in development of plague vaccines against biowarfare. Expert Rev Vaccines; 2011 Mar; 10(3):259. PubMed ID: 21434794 [No Abstract] [Full Text] [Related]
18. Further development of raccoon poxvirus-vectored vaccines against plague (Yersinia pestis). Rocke TE; Iams KP; Dawe S; Smith SR; Williamson JL; Heisey DM; Osorio JE Vaccine; 2009 Dec; 28(2):338-44. PubMed ID: 19879228 [TBL] [Abstract][Full Text] [Related]